Endotoxin Testing with Sustainable rFC: New Pharmacopoeia Developments and Implementation for Routine Use
You are invited to our Endotoxin Webinar!
Format: Online Webinar (free of charge)
You will learn:
- How regulatory developments are shaping recombinant endotoxin testing, including key updates of pharmacopoeial chapters and their impact on rFC-based methods.
- How bioMérieux's ENDONEXT™ rFC Solutions comply with new Pharmacopoeia Developments with ease-of-use, robustness, and sustainability, from performance benefits to practical applications in QC labs.
- How the implementation of ENDONEXT™ rFC Solutions has optimized the testing process in a contract service laboratory for pharma and medical device, with insights from validation and routine use.
- Live Q&A Session: Stay for a live Q&A session where our experts will address your questions
Who should attend:
- Quality Control (QC) and Quality Assurance (QA)
- Laboratory Management, Microbiology, and Analytical Development
- Biopharmaceutical Manufacturing and Testing Services
Speakers:
- Alessandro Pauletto Global LER Business Development Manager
- Karolina Heed bioMérieux Business Development Manager, Central Europe
- Stefan Karl CEO, MPL-Mikrobiologisches Prüflabor GmbH, Austria
